microRNAs in parasite-induced liver fibrosis: from mechanisms to diagnostics and therapeutics

Torgerson, 2015, World Health Organization estimates of the global and regional disease burden of 11 foodborne parasitic diseases, 2010: a data synthesis, PLoS Med., 12, 10.1371/journal.pmed.1001920 Peters, 2021, Parasites of the liver – epidemiology, diagnosis and clinical management in the European context, J. Hepatol., 75, 202, 10.1016/j.jhep.2021.02.015 McManus, 2020, Schistosomiasis-from immunopathology to vaccines, Semin. Immunopathol., 42, 355, 10.1007/s00281-020-00789-x Diaz, 2018, Granulomatous responses in larval taeniid infections, Parasite Immunol., 40, 10.1111/pim.12523 Yang, 2022, Transplantation of adipose-derived stem cells ameliorates Echinococcus multilocularis-induced liver fibrosis in mice, PLoS Negl. Trop. Dis., 16, 10.1371/journal.pntd.0010175 Kamiyama, 2020, Recent advances in surgical strategies for alveolar echinococcosis of the liver, Surg. Today, 50, 1360, 10.1007/s00595-019-01922-6 Sombetzki, 2015, Vector-mediated microRNA-21 silencing ameliorates granulomatous liver fibrosis in Schistosoma japonicum infection, Hepatology, 61, 1787, 10.1002/hep.27748 Chong, 2022, Echinococcus multilocularis drives the polarization of macrophages by regulating the RhoA-MAPK signaling pathway and thus affects liver fibrosis, Bioengineered, 13, 8747, 10.1080/21655979.2022.2056690 Gines, 2021, Liver cirrhosis, Lancet, 398, 1359, 10.1016/S0140-6736(21)01374-X Henderson, 2020, Fibrosis: from mechanisms to medicines, Nature, 587, 555, 10.1038/s41586-020-2938-9 Ghafouri-Fard, 2021, Role of miRNA and lncRNAs in organ fibrosis and aging, Biomed. Pharmacother., 143, 10.1016/j.biopha.2021.112132 Wu, 2020, Argonaute proteins: structural features, functions and emerging roles, J. Adv. Res., 24, 317, 10.1016/j.jare.2020.04.017 Tang, 2023, Cardiomyocyte-specific Peli1 contributes to the pressure overload-induced cardiac fibrosis through miR-494-3p-dependent exosomal communication, FASEB J., 37, 10.1096/fj.202200597R Wan, 2023, Liver-specific deletion of microRNA-34a alleviates ductular reaction and liver fibrosis during experimental cholestasis, FASEB J., 37, 10.1096/fj.202201453R Bu, 2022, LncRNA H19 via miR-29a-3p is involved in lung inflammation and pulmonary fibrosis induced by neodymium oxide, Ecotoxicol. Environ. Saf., 247, 10.1016/j.ecoenv.2022.114173 Zheng, 2013, microRNAs in parasites and parasite infection, RNA Biol., 10, 371, 10.4161/rna.23716 Yan, 2021, Csi-let-7a-5p delivered by extracellular vesicles from a liver fluke activates M1-like macrophages and exacerbates biliary injuries, Proc. Natl. Acad. Sci. U. S. A., 118, 10.1073/pnas.2102206118 Acharya, 2021, Schistosome immunomodulators, PLoS Pathog., 17, 10.1371/journal.ppat.1010064 Wang, 2022, Host liver-derived extracellular vesicles deliver miR-142a-3p induces neutrophil extracellular traps via targeting WASL to block the development of Schistosoma japonicum, Mol. Ther., 30, 2092, 10.1016/j.ymthe.2022.03.016 Meng, 2022, The role of hepatic microenvironment in hepatic fibrosis development, Ann. Med., 54, 2830, 10.1080/07853890.2022.2132418 Abd El-Fattah, 2022, Targeting HSP47 and HSP70: promising therapeutic approaches in liver fibrosis management, J. Transl. Med., 20, 544, 10.1186/s12967-022-03759-z Kisseleva, 2021, Molecular and cellular mechanisms of liver fibrosis and its regression, Nat. Rev. Gastroenterol. Hepatol., 18, 151, 10.1038/s41575-020-00372-7 Koda, 2022, Regulation of progression and resolution of liver fibrosis by immune cells, Semin. Liver Dis., 42, 475, 10.1055/a-1957-6384 Hao, 2022, The pathogenesis of organ fibrosis: focus on necroptosis, Br. J. Pharmacol., 10.1111/bph.15952 Gaul, 2021, Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis, J. Hepatol., 74, 156, 10.1016/j.jhep.2020.07.041 Zhang, 2022, The molecular mechanisms of liver fibrosis and its potential therapy in application, Int. J. Mol. Sci., 23, 12572, 10.3390/ijms232012572 Li, 2022, Extracellular vesicles: catching the light of intercellular communication in fibrotic liver diseases, Theranostics, 12, 6955, 10.7150/thno.77256 An, 2020, Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis, Nat. Commun., 11, 2362, 10.1038/s41467-020-16092-0 David, 2018, Contextual determinants of TGFbeta action in development, immunity and cancer, Nat. Rev. Mol. Cell Biol., 19, 419, 10.1038/s41580-018-0007-0 Vander Ark, 2018, TGF-beta receptors: in and beyond TGF-beta signaling, Cell. Signal., 52, 112, 10.1016/j.cellsig.2018.09.002 Zheng, 2022, Gut microbiota combined with metabolomics reveal the mechanism of curcumol on liver fibrosis in mice, Biomed. Pharmacother., 152, 10.1016/j.biopha.2022.113204 Zhang, 2022, The gut microbiota-bile acid axis: a potential therapeutic target for liver fibrosis, Front. Cell. Infect. Microbiol., 12 Ren, 2023, Longitudinal immune profiling highlights CD4+ T cell exhaustion correlated with liver fibrosis in Schistosoma japonicum infection, J. Immunol., 210, 82, 10.4049/jimmunol.2200301 Chuah, 2014, Cellular and chemokine-mediated regulation in schistosome-induced hepatic pathology, Trends Parasitol., 30, 141, 10.1016/j.pt.2013.12.009 Zheng, 2013, Strategies of Echinococcus species responses to immune attacks: implications for therapeutic tool development, Int. Immunopharmacol., 17, 495, 10.1016/j.intimp.2013.07.022 Hidalgo, 2021, Response patterns in adventitial layer of Echinococcus granulosus sensu stricto cysts from naturally infected cattle and sheep, Vet. Res., 52, 66, 10.1186/s13567-021-00936-8 Niu, 2019, Mechanism of fibrosis induced by Echinococcus spp, Diseases, 7, 51, 10.3390/diseases7030051 Rojas-Pirela, 2022, microRNAs: critical players during helminth infections, Microorganisms, 11, 61, 10.3390/microorganisms11010061 He, 2020, A schistosome miRNA promotes host hepatic fibrosis by targeting transforming growth factor beta receptor III, J. Hepatol., 72, 519, 10.1016/j.jhep.2019.10.029 Wang, 2020, Sja-miR-71a in schistosome egg-derived extracellular vesicles suppresses liver fibrosis caused by schistosomiasis via targeting semaphorin 4D, J. Extracell. Vesicles, 9, 10.1080/20013078.2020.1785738 Wang, 2020, A microRNA derived from Schistosoma japonicum promotes schistosomiasis hepatic fibrosis by targeting host secreted frizzled-related protein 1, Front. Cell. Infect. Microbiol., 10, 101, 10.3389/fcimb.2020.00101 Zheng, 2022, Autophagy of hepatic stellate cell induced by Clonorchis sinensis, Mol. Biol. Rep., 49, 1895, 10.1007/s11033-021-07001-9 Duspara, 2021, Targeting the Wnt signaling pathway in liver fibrosis for drug options: an update, J. Clin. Transl. Hepatol., 9, 960 Hochreuter, 2022, MicroRNAs in non-alcoholic fatty liver disease: progress and perspectives, Mol. Metab., 65, 10.1016/j.molmet.2022.101581 Wang, 2017, Antischistosomiasis liver fibrosis effects of chlorogenic acid through IL-13/miR-21/Smad7 signaling interactions in vivo and in vitro, Antimicrob. Agents Chemother., 61, 10.1128/AAC.01347-16 He, 2015, Recombinant adeno-associated virus-mediated inhibition of microRNA-21 protects mice against the lethal schistosome infection by repressing both IL-13 and transforming growth factor beta 1 pathways, Hepatology, 61, 2008, 10.1002/hep.27671 Luo, 2018, MicroRNA-96 promotes schistosomiasis hepatic fibrosis in mice by suppressing Smad7, Mol. Ther. Methods Clin. Dev., 11, 73, 10.1016/j.omtm.2018.10.002 Wang, 2022, MicroRNA-181b promotes schistosomiasis-induced hepatic fibrosis by targeting Smad7, Mol. Biochem. Parasitol., 252, 10.1016/j.molbiopara.2022.111523 Wynn, 2004, Immunopathogenesis of schistosomiasis, Immunol. Rev., 201, 156, 10.1111/j.0105-2896.2004.00176.x Liu, 2011, IL-13 induces connective tissue growth factor in rat hepatic stellate cells via TGF-beta-independent Smad signaling, J. Immunol., 187, 2814, 10.4049/jimmunol.1003260 Kindermann, 2018, ILC2s in infectious diseases and organ-specific fibrosis, Semin. Immunopathol., 40, 379, 10.1007/s00281-018-0677-x Huang, 2018, Effect of miR-182 on hepatic fibrosis induced by Schistosoma japonica by targeting FOXO1 through PI3K/AKT signaling pathway, J. Cell. Physiol., 233, 6693, 10.1002/jcp.26469 Zhao, 2022, miR-182-5p attenuates Schistosoma japonicum-induced hepatic fibrosis by targeting tristetraprolin, Acta Biochim. Biophys. Sin. Shanghai, 54, 1421, 10.3724/abbs.2022130 Zhu, 2014, Expression of microRNA-454 in TGF-beta1-stimulated hepatic stellate cells and in mouse livers infected with Schistosoma japonicum, Parasit. Vectors, 7, 148, 10.1186/1756-3305-7-148 Zhao, 2019, Mmu-miR-92a-2-5p targets TLR2 to relieve Schistosoma japonicum-induced liver fibrosis, Int. Immunopharmacol., 69, 126, 10.1016/j.intimp.2019.01.007 Liu, 2021, MiR-130a-3p alleviates liver fibrosis by suppressing HSCs activation and skewing macrophage to Ly6C(lo) phenotype, Front. Immunol., 12 Xu, 2021, MicroRNA 200a inhibits liver fibrosis of schistosoma, Bioengineered, 12, 4736, 10.1080/21655979.2021.1950441 Hu, 2016, Interleukin-22 ameliorates liver fibrosis through miR-200a/beta-catenin, Sci. Rep., 6, 36436, 10.1038/srep36436 Yang, 2017, miR-200a controls hepatic stellate cell activation and fibrosis via SIRT1/Notch1 signal pathway, Inflamm. Res., 66, 341, 10.1007/s00011-016-1020-4 Li, 2020, Gli3 is a novel downstream target of miR-200a with an anti- fi brotic role for progression of liver fibrosis in vivo and in vitro, Mol. Med. Rep., 21, 1861 Fang, 2021, Prediction and verification of target of helenalin against hepatic stellate cell activation based on miR-200a-mediated PI3K/Akt and NF-kappaB pathways, Int. Immunopharmacol., 92, 10.1016/j.intimp.2020.107208 Liao, 2021, A lncRNA Gpr137b-ps/miR-200a-3p/CXCL14 axis modulates hepatic stellate cell (HSC) activation, Toxicol. Lett., 336, 21, 10.1016/j.toxlet.2020.10.001 Lee, 2021, Schistosoma egg antigens suppress LPS-induced inflammation in human IMR-90 cells by modulation of JAK/STAT1 signaling, J. Microbiol. Immunol. Infect., 54, 501, 10.1016/j.jmii.2019.12.001 Ni, 2021, Therapeutic inhibition of miR-802 protects against obesity through AMPK-mediated regulation of hepatic lipid metabolism, Theranostics, 11, 1079, 10.7150/thno.49354 Mouser, 2019, Schistosoma mansoni soluble egg antigen (SEA) and recombinant Omega-1 modulate induced CD4+ T-lymphocyte responses and HIV-1 infection in vitro, PLoS Pathog., 15, 10.1371/journal.ppat.1007924 Sun, 2021, The role of let-7b in the inhibition of hepatic stellate cell activation by rSjP40, PLoS Negl. Trop. Dis., 15, 10.1371/journal.pntd.0009472 von Bulow, 2023, Metabolic reprogramming of hepatocytes by Schistosoma mansoni eggs, JHEP Rep., 5 Wang, 2020, Upregulation of KSRP by miR-27b attenuates schistosomiasis-induced hepatic fibrosis by targeting TGF-beta1, FASEB J., 34, 4120, 10.1096/fj.201902438R Chen, 2019, rSjp40 inhibits activated hepatic stellate cells by promoting nuclear translocation of YB1 and inducing BMP-7/Smad1/5/8 pathway, Parasit. Vectors, 12, 279, 10.1186/s13071-019-3539-z Chen, 2016, Egg antigen p40 of Schistosoma japonicum promotes senescence in activated hepatic stellate cells by activation of the STAT3/p53/p21 pathway, Cell Death Dis., 7, 10.1038/cddis.2016.228 Zhu, 2018, rSjP40 suppresses hepatic stellate cell activation by promoting microRNA-155 expression and inhibiting STAT5 and FOXO3a expression, J. Cell. Mol. Med., 22, 5486, 10.1111/jcmm.13819 Cai, 2013, MicroRNA-gene expression network in murine liver during Schistosoma japonicum infection, PLoS One, 8 Tang, 2017, Lentivirus-mediated over-expression of let-7b microRNA suppresses hepatic fibrosis in the mouse infected with Schistosoma japonicum, Exp. Parasitol., 182, 45, 10.1016/j.exppara.2017.09.024 Qian, 2016, Clonorchiasis, Lancet, 387, 800, 10.1016/S0140-6736(15)60313-0 Qi, 2022, Clonorchis sinensis infection contributes to hepatocellular carcinoma progression in rat, Parasitol. Res., 121, 3403, 10.1007/s00436-022-07699-x Xiao, 2019, Long noncoding RNA H19 contributes to cholangiocyte proliferation and cholestatic liver fibrosis in biliary atresia, Hepatology, 70, 1658, 10.1002/hep.30698 Zhou, 2021, MicroRNA-497 induced by Clonorchis sinensis enhances the TGF-beta/Smad signaling pathway to promote hepatic fibrosis by targeting Smad7, Parasit. Vectors, 14, 472, 10.1186/s13071-021-04972-3 Yan, 2016, Characterization and identification of differentially expressed microRNAs during the process of the peribiliary fibrosis induced by Clonorchis sinensis, Infect. Genet. Evol., 43, 321, 10.1016/j.meegid.2016.06.009 Liu, 2022, Integrative analysis of RNA expression and regulatory networks in mice liver infected by Echinococcus multilocularis, Front. Cell Dev. Biol., 10 Jin, 2017, miRNA profiling in the mice in response to Echinococcus multilocularis infection, Acta Trop., 166, 39, 10.1016/j.actatropica.2016.10.024 Mirzavand, 2020, Gene expression in human liver fibrosis associated with Echinococcus granulosus sensu lato, Parasitol. Res., 119, 2177, 10.1007/s00436-020-06700-9 Zhang, 2016, Hydatid cyst fluid promotes peri-cystic fibrosis in cystic echinococcosis by suppressing miR-19 expression, Parasit. Vectors, 9, 278, 10.1186/s13071-016-1562-x Pi, 2022, LncRNA XIST accelerates burn wound healing by promoting M2 macrophage polarization through targeting IL-33 via miR-19b, Cell Death Discov., 8, 220, 10.1038/s41420-022-00990-x Chen, 2021, Tumor-derived exosomal miR-19b-3p facilitates M2 macrophage polarization and exosomal LINC00273 secretion to promote lung adenocarcinoma metastasis via Hippo pathway, Clin. Transl. Med., 11, 10.1002/ctm2.478 Wang, 2020, Dual role of hepatic macrophages in the establishment of the Echinococcus multilocularis metacestode in mice, Front. Immunol., 11 Wang, 2021, MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases, Gut, 70, 784, 10.1136/gutjnl-2020-322526 Koffas, 2022, Hepatitis delta virus: disease assessment and stratification, J. Viral Hepat., 30, 12, 10.1111/jvh.13777 Cai, 2018, Circulating miRNAs as footprints for liver fibrosis grading in schistosomiasis, EBioMedicine, 37, 334, 10.1016/j.ebiom.2018.10.048 Cai, 2020, Serum exosomal miRNAs for grading hepatic fibrosis due to schistosomiasis, Int. J. Mol. Sci., 21, 3560, 10.3390/ijms21103560 Tabios, 2022, Circulating microRNAs as biomarkers of hepatic fibrosis in Schistosomiasis japonica patients in the Philippines, Diagnostics (Basel), 12, 1902, 10.3390/diagnostics12081902 Silakit, 2017, Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group, Parasitol. Int., 66, 479, 10.1016/j.parint.2015.10.001 Silakit, 2014, Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator, J Hepatobiliary Pancreat Sci, 21, 864, 10.1002/jhbp.145 Maestro, 2021, Novel vectors and approaches for gene therapy in liver diseases, JHEP Rep., 3 Johnson, 2022, Lipid nanoparticle (LNP) chemistry can endow unique in vivo RNA delivery fates within the liver that alter therapeutic outcomes in a cancer model, Mol. Pharm., 19, 3973, 10.1021/acs.molpharmaceut.2c00442 Hu, 2021, Hepatic macrophages act as a central hub for relaxin-mediated alleviation of liver fibrosis, Nat. Nanotechnol., 16, 466, 10.1038/s41565-020-00836-6 Mahdinloo, 2020, Efficient drug and gene delivery to liver fibrosis: rationale, recent advances, and perspectives, Acta Pharm. Sin. B, 10, 1279, 10.1016/j.apsb.2020.03.007 Melamed, 2023, Ionizable lipid nanoparticles deliver mRNA to pancreatic beta cells via macrophage-mediated gene transfer, Sci. Adv., 9, 10.1126/sciadv.ade1444 Han, 2023, Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis, Nat. Commun., 14, 75, 10.1038/s41467-022-35637-z Surendran, 2020, A bilirubin-conjugated chitosan nanotheranostics system as a platform for reactive oxygen species stimuli-responsive hepatic fibrosis therapy, Acta Biomater., 116, 356, 10.1016/j.actbio.2020.09.014 Ning, 2019, Delivery of liver-specific miRNA-122 using a targeted macromolecular prodrug toward synergistic therapy for hepatocellular carcinoma, ACS Appl. Mater. Interfaces, 11, 10578, 10.1021/acsami.9b00634 Sun, 2022, Efficient delivery of Echinococcus multilocularis miRNAs using chitosan nanoparticles, Biomed. Pharmacother., 150, 10.1016/j.biopha.2022.112945 El-Safy, 2020, Collagenase loaded chitosan nanoparticles for digestion of the collagenous scar in liver fibrosis: the effect of chitosan intrinsic collagen binding on the success of targeting, Eur. J. Pharm. Biopharm., 148, 54, 10.1016/j.ejpb.2020.01.003 Wu, 2022, Preparation of betulinic acid galactosylated chitosan nanoparticles and their effect on liver fibrosis, Int. J. Nanomedicine, 17, 4195, 10.2147/IJN.S373430 Tian, 2022, Mesenchymal stem cell-derived exosomes protect against liver fibrosis via delivering miR-148a to target KLF6/STAT3 pathway in macrophages, Stem Cell Res Ther, 13, 330, 10.1186/s13287-022-03010-y Wang, 2021, 3D hESC exosomes enriched with miR-6766-3p ameliorates liver fibrosis by attenuating activated stellate cells through targeting the TGFbetaRII-SMADS pathway, J. Nanobiotechnol., 19, 437, 10.1186/s12951-021-01138-2 Garcia-Martin, 2022, MicroRNA sequence codes for small extracellular vesicle release and cellular retention, Nature, 601, 446, 10.1038/s41586-021-04234-3 You, 2021, Vitamin A-coupled stem cell-derived extracellular vesicles regulate the fibrotic cascade by targeting activated hepatic stellate cells in vivo, J. Control. Release, 336, 285, 10.1016/j.jconrel.2021.06.031 Diener, 2022, Emerging concepts of miRNA therapeutics: from cells to clinic, Trends Genet., 38, 613, 10.1016/j.tig.2022.02.006 Bonneau, 2019, How close are miRNAs from clinical practice? A perspective on the diagnostic and therapeutic market, EJIFCC, 30, 114 Almanzar, 2023, 5-FU-miR-15a inhibits activation of pancreatic stellate cells by reducing YAP1 and BCL-2 levels in vitro, Int. J. Mol. Sci., 24, 3954, 10.3390/ijms24043954 Yang, 2016, Effect of Corilagin on the miR-21/smad7/ERK signaling pathway in a schistosomiasis-induced hepatic fibrosis mouse model, Parasitol. Int., 65, 308, 10.1016/j.parint.2016.03.001 Wang, 2021, A combination of pirfenidone and TGF-beta inhibition mitigates cystic echinococcosis-associated hepatic injury, Parasitology, 148, 767, 10.1017/S0031182021000287 Santos, 2020, Host miRNA-21 promotes liver dysfunction by targeting small intestinal Lactobacillus in mice, Gut Microbes, 12, 1, 10.1080/19490976.2020.1840766 Lin, 2022, Potential gut microbiota features for non-invasive detection of schistosomiasis, Front. Immunol., 13 Ketpueak, 2020, Association of chronic opisthorchis infestation and microbiota alteration on tumorigenesis in cholangiocarcinoma, Clin. Transl. Gastroenterol., 12 Kirundi, 2023, Microbiome-liver crosstalk: a multihit therapeutic target for liver disease, World J. Gastroenterol., 29, 1651, 10.3748/wjg.v29.i11.1651 Yang, 2023, Metformin alleviates liver fibrosis in mice by enriching Lactobacillus sp. MF-1 in the gut microbiota, Biochim. Biophys. Acta Mol. basis Dis., 1869, 10.1016/j.bbadis.2023.166664